000 | 01032 a2200277 4500 | ||
---|---|---|---|
005 | 20250516172138.0 | ||
264 | 0 | _c20140210 | |
008 | 201402s 0 0 jpn d | ||
022 | _a0485-1439 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTauchi, Tetsuzo | |
245 | 0 | 0 |
_a[3rd generation ABL kinase inhibitor and Philadelphia chromosome positive leukemia]. _h[electronic resource] |
260 |
_b[Rinsho ketsueki] The Japanese journal of clinical hematology _cOct 2013 |
||
300 |
_a1682-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImidazoles _xchemistry |
650 | 0 | 4 |
_aLeukemia _xdiagnosis |
650 | 0 | 4 |
_aPhiladelphia Chromosome _xdrug effects |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPyridazines _xchemistry |
773 | 0 |
_t[Rinsho ketsueki] The Japanese journal of clinical hematology _gvol. 54 _gno. 10 _gp. 1682-6 |
|
999 |
_c23115866 _d23115866 |